GRI Bio Inc. (GRI)
GRI trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.55
-1.27% on the day
Market cap
$3.4M
Nano cap
Revenue
No annual revenue filed since the period ending 2021-12-31
Net income
No annual revenue filed since the period ending 2021-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | GRI on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001824293 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
No annual revenue filed since the period ending 2021-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-01-30 |
| Latest annual report | 10-K | 2026-01-30 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report | 8-K | 2026-09-08 |
| Latest proxy | DEF 14A | 2026-09-28 |
Source: SEC EDGAR submissions feed, 401 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| EOCN | Eocene Ltd. | $3.17 | -1.71% | $3.3M |
| CAPS | Capstone Holding Corp. | $0.1242 | -6.83% | $3.3M |
| CVKD | Cadrenal Therapeutics Inc. | $0.9970 | +14.28% | $3.6M |
| SBFM | Sunshine Biopharma Inc. | $0.2363 | -21.75% | $3.6M |
| SXTP | 60 Degrees Pharmaceuticals Inc. | $0.9000 | -1.70% | $3.2M |
| CMND | Clearmind Medicine Inc. Common Shares | $6.23 | -4.74% | $3.2M |
| RDHL | Redhill Biopharma Ltd. | $0.5150 | -3.45% | $3.1M |
| APVO | Aptevo Therapeutics Inc. | $1.73 | -5.79% | $3.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier